Dan Schoen Email & Phone Number

Chicago/Cambridge

I lead pricing and reimbursement strategies globally for Onpattro and Amvuttra, focusing particularly on the cardiomyopathy launch and expanding franchise indications, while providing critical access insights into pipeline development. I collaborate extensively across functions to develop and implement pricing strategies and launch sequencing, representing market access on the TTR leadership team and providing critical insights and strategic direction.Key Accomplishments:➛ Spearheaded the development and implementation of the first integrated access strategy at Alnylam for the TTR franchise, transforming our approach to market access.➛ Established pricing policy and guidance governance, improving efficiency and clarity in pricing strategies organization-wide.➛ Led the long-range planning process for global market access, offering vital insights and strategic direction for future initiatives.➛ Successfully negotiated pricing and access agreements in partner and emerging markets, optimizing market entry and ensuring competitive pricing for TTR franchise products.➛ Presented portfolio analysis insights at an executive level, influencing decision-making processes and shaping strategic directions for future initiatives.

Chicago, Illinois, United States

I led the c-MET franchise at AbbVie, overseeing three pipeline assets, including Teliso-V in NSCLC, which will hopefully be AbbVie's inaugural solid tumor launch. In this role, I established and led the Value and Access Teams, responsible for developing integrated access strategies for each asset and the overall franchise. I directed solid tumor business development assessments, guiding strategic decisions aligned with franchise objectives. I played a crucial role in shaping trial designs to optimize access and pricing strategies, navigating through various market complexities.Key Accomplishments:➛ Successfully advanced the c-MET franchise within the challenging landscape of NSCLC.➛ Fostered a positive team environment, ensuring high morale and sustained focus on strategic objectives.➛ Contributed significantly to the development of an integrated access strategy, enabling optimal market entry for pipeline assets.

Chicago, Illinois, United States

I oversaw the lifecycle strategy for Venetoclax at AbbVie, focusing on launch planning for Mantle Cell Lymphoma and renegotiations for r/r CLL indications. My role involved developing orphan strategies across various indications to ensure strategic market entry. I was responsible for managing LOE pricing strategy and solid tumor access plans for Venetoclax, providing strategic direction within the Global Brand Team (GBT) framework.Key Accomplishments:➛ Successfully executed launch strategies for Mantle Cell Lymphoma and r/r CLL, driving substantial market adoption.➛ Developed and implemented orphan strategies, effectively optimizing market access strategies while preserving asset value.➛ Implemented impactful LOE pricing strategies and solid tumor access plans, maximizing revenue potential and enhancing market presence.

Chicago, Illinois, United States

I managed global price bands, launch sequencing, and International Reference Pricing (IRP) impacts for AbbVie's Hematology franchise, focusing on Venetoclax and Navitoclax. I led the launch efforts for Venetoclax, overseeing strategies for both monotherapy and combination therapy. My role included conducting lifecycle planning and indication sequencing, ensuring strategic alignment pre and post Loss of Exclusivity (LOE). I maintained expertise in payer environments across major markets, with a particular emphasis on Oncology coverage, reimbursement, pricing, Health Technology Assessment (HTA), and healthcare policy. I presented complex pricing analyses bi-weekly to the Chief Commercial Officer, translating insights into actionable strategies. Additionally, I developed innovative contracting concepts for execution at the affiliate level, addressing complexities in combination pricing and value differentiation.Key Accomplishments:➛ Launched Venetoclax successfully as both monotherapy and combination therapy, demonstrating strategic agility and adaptability.➛ Earned multiple prestigious awards, including President's Awards and Best-in-Class Awards, for outstanding performance in pricing and reimbursement strategy.➛ Implemented innovative contracting concepts that drove record achievements in pricing and reimbursement, enhancing AbbVie's competitive positioning in challenging markets.

Chicago

Provided vision and pricing insights for Humira and biosimilars, contributing to strategic pricing strategies pre and post loss of exclusivity. Recognized with a President's Award for impactful contributions to pricing strategy.

Chicago, Illinois, United States

Managed $900M P&L expenses and $1B inventory, supporting operational planning and deployment. Led financial analysis and strategic decision-making for market demand fluctuations.

Chicago

Guided financial support and insights for Abbott Nutrition Supply Chain operations. Led volume alignment efforts across Supply Chain and Commercial functional areas, optimizing planning processes.Finance Manager, Nutrition Supply ChainSr. Analyst, Long Range Planning (Nutrition International)FP&A Manager, Colombian Affiliate (Nutrition International)Sr. FP&A Analyst (Nutrition International)Cost Analyst, Corporate Manufacturing Accounting

San Francisco Bay Area

Analyzed financial statements for businesses, supervised business bankers, and achieved top ranking in Northern California division for sales performance.

Master Of Business Administration - Mba

Bachelor'S Degree, Finance, General

Bachelor'S Degree, Electrical And Electronics Engineering